Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;10(2):156-167.
doi: 10.2174/1573400510666140320000928.

Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence

Chetna J Mistry  1 , Monica Bawor  2 , Dipika Desai  3 , David C Marsh  4 , Zainab Samaan  5
Affiliations
Free PMC article

Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence

Chetna J Mistry et al. Curr Psychiatry Rev. 2014 May.
Free PMC article

Abstract

This narrative review aims to provide an overview of the impact of opioid dependence and the contribution of genetics to opioid dependence. Epidemiological data demonstrate that opioid dependence is a global trend with far-reaching effects on the social, economic, and health care systems. A review of classical genetic studies of opioid use suggests significant heritability of drug use behavior, however the evidence from molecular genetic studies is inconclusive. Nonetheless, certain genetic variants are important to consider given their role in the pathophysiology of addictive behavior. We undertook a literature review to identify the current state of knowledge regarding the role of genes in opioid dependence. Determining the association of genetic markers could change the current understanding of the various factors contributing to opioid dependence and therefore may improve recognition of individuals at risk for the disorder and prevention and treatment strategies.

Keywords: Dependence; SNP.; genes; opioid; opioid addiction; opioid receptors.

PubMed Disclaimer

References

    1. Fischer B, Rehm J, Patra J, Cruz MF. Changes in illicit opioid use across Canada. CMAJ. 2006;175(11):1385. - PMC - PubMed
    1. Fischer B, Cruz MF, Rehm J. Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry. 2006;51(10):624–34. - PubMed
    1. Fishbain D, Johnson S, Webster L, Greene L, Faysal J. Review of regulatory programs and new opioid technologies in chronic pain management: Balancing the risk of medication abuse with medical need. J Manag Care Pharm. 2010;16(4):276–87. - PMC - PubMed
    1. Fischer B, Rehm J, Goldman B, Popova S. Non-medical use of prescription opioids and public health in Canada: An urgent call for research and interventions development. Can J Public Health. 2008;99(3):182–4. - PMC - PubMed
    1. Hassouneh B, Centofanti JE, Reddy K. Pain management in postcraniotomy patients: A survey of canadian neurosurgeons. Can J Neurol Sci. 2011;38(3):456–60. - PubMed